Stock Price Movement and Market Context
On the day, Hikal Ltd’s stock touched an intraday low of Rs.165.45, representing a 4.75% decline from the previous close. This fall came after two consecutive days of gains, signalling a reversal in short-term momentum. The stock’s day change was -3.86%, underperforming the Pharmaceuticals & Drugs sector, which itself declined by 2.01%. Hikal’s share price is currently trading below all key moving averages — 5-day, 20-day, 50-day, 100-day, and 200-day — indicating a sustained bearish trend.
The broader market environment has also been challenging. The Sensex opened sharply lower by 1,953.21 points and further declined by 543.68 points to close at 74,207.24, down 3.26%. The benchmark index is nearing its 52-week low of 71,425.01, currently just 3.75% away. The Sensex has been on a three-week losing streak, shedding 8.71% in that period, and is trading below its 50-day moving average, which itself is below the 200-day moving average — a classic bearish signal.
Financial Performance and Fundamental Metrics
Hikal Ltd’s financial performance has been under pressure over the past year and longer term. The stock has delivered a negative return of 58.66% over the last 12 months, significantly underperforming the Sensex’s modest decline of 1.65% in the same period. The company’s 52-week high was Rs.456.60, highlighting the extent of the recent decline.
Long-term fundamentals reveal a compound annual growth rate (CAGR) of -16.94% in operating profits over the last five years, indicating a contraction in core earnings. The company’s ability to service debt is limited, with a Debt to EBITDA ratio of 2.51 times, reflecting elevated leverage. Profitability metrics also remain subdued, with an average Return on Equity (ROE) of 8.00%, signalling modest returns on shareholders’ funds.
Recent results for the half-year ended December 2025 were largely flat, with the Return on Capital Employed (ROCE) at a low 4.44%, underscoring limited efficiency in capital utilisation. Profitability has deteriorated sharply, with profits falling by 66.4% over the past year, further weighing on investor sentiment.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Valuation and Comparative Analysis
Despite the weak financial performance, Hikal Ltd’s valuation metrics suggest the stock is trading at a discount relative to its peers. The company’s ROCE stands at 4.1%, and it has an Enterprise Value to Capital Employed ratio of 1.5, which is considered attractive in the current market context. This valuation discount reflects the market’s cautious stance given the company’s recent earnings decline and subdued profitability.
However, the stock’s long-term performance remains below par, having underperformed the BSE500 index over the last three years, one year, and three months. This persistent underperformance highlights ongoing challenges in regaining investor confidence and improving financial metrics.
Technical Indicators and Market Sentiment
Technical analysis of Hikal Ltd’s stock reveals predominantly bearish signals across multiple timeframes. The Moving Average Convergence Divergence (MACD) indicator is bearish on both weekly and monthly charts. The Relative Strength Index (RSI) shows no clear signal but remains subdued. Bollinger Bands indicate mild to moderate bearishness, while the Know Sure Thing (KST) oscillator is bearish on weekly and monthly scales.
Other technical tools, including Dow Theory and On-Balance Volume (OBV), suggest mild bearishness or no clear trend, reinforcing the overall cautious technical outlook. The stock’s daily moving averages remain bearish, consistent with the recent price declines and the breach of key support levels.
Is Hikal Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!
- - Better alternatives suggested
- - Cross-sector comparison
- - Portfolio optimization tool
Shareholding and Market Capitalisation
Hikal Ltd is classified as a small-cap company within the Pharmaceuticals & Biotechnology sector. The majority shareholding rests with promoters, indicating concentrated ownership. The company’s Mojo Score stands at 23.0, with a Mojo Grade of Strong Sell as of 14 Nov 2025, an upgrade from the previous Sell rating. This grading reflects the company’s weak long-term fundamentals and recent financial performance.
The stock’s underperformance relative to the sector and benchmark indices, combined with its technical and fundamental indicators, has contributed to the current valuation and price levels.
Summary of Key Metrics
To summarise, Hikal Ltd’s stock has declined to Rs.165.45, its lowest level in 52 weeks, amid a challenging market and sector environment. The stock’s 1-year return of -58.66% contrasts sharply with the Sensex’s -1.65% over the same period. Operating profits have contracted at a CAGR of -16.94% over five years, and recent profits have fallen by 66.4%. The company’s leverage remains elevated with a Debt to EBITDA ratio of 2.51 times, while profitability metrics such as ROE and ROCE remain subdued at 8.00% and 4.44% respectively.
Technical indicators predominantly signal bearish trends, with the stock trading below all major moving averages and showing negative momentum across multiple oscillators. The broader market and sector have also experienced declines, compounding pressure on the stock price.
These factors collectively explain the stock’s fall to its 52-week low and the current market positioning of Hikal Ltd within the Pharmaceuticals & Biotechnology sector.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
